Skip to content
★ Sign in to follow
토모

토모큐브 Stock: price and insider trades · South Korea

KR·Mcap ₩436.3BHealth Care

No insider purchase over the last 90 days. The latest, by 고성호, was filed 15 Jul 2026.

토모큐브: what insiders have been doing

토모큐브, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). The last twelve months, up to 1 November 2026, brought 6 filings signed by 5 insiders.

The record shows 4 purchases on the open market, made by 3 insiders, against 1 sale by 1 insider. The amount is not disclosed for 5 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 1 board member and 1 senior executive among the declarants.

The clock since the last published purchase (15 July 2026) now reads 118 days.

Compared with its exchange (2,655 companies, median 7 filings), a count of 6 filings is below the norm. Since 2024, the database holds 14 purchases and 2 sales by insiders of the company.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
18
Thresholds
n/a
Buy Volume
€79M
14 ops. · all time
Sell Volume
€2M
2 ops. · all time

Who traded when

BuySale
김태홍2 buys1 sale
고성호2 buys
이수민2 buys
데일리파트너스1 sale
박용근1 buy
오경태1 buy
Fundamental score
Ranked 20,977 of 26,911 companies
32.3
score / 100
Value
28
Quality
36
FCF yld-2.3%
Earn yld-1.4%
EV/EBITDA·
ROE-6.4%
Gross mgn66%
Net mgn-43%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩32,600
Analyst consensus
·
Income statement
Revenue₩11.3B
Gross profit₩7.4B66% margin
EBITDA-₩3.2B-29% margin
Net income-₩4.8B-16.1% margin
Valuation
PER (forward)29.3x
Balance sheet & cash
Market cap₩436.3B
Total debt₩1.1B
Free Cash Flow-₩7.5B
Debt / Equity2%
Profitability & ownership
ROE-6.4%
ROA-5.8%
% insiders26.4%
% institutions0.7%
Last declaration on 15 July 2026
Declarations18 total
  • ▲
    COOExecutives(filed)
    €445kest.0DART
    20,000 sharesShareKRXDART:20260715000020
    Canonical exit: 13 Oct 2026 (T+90)
  • ▲
    Executives
    €344kest.0DART
    13,139 sharesKRXDART:20260528000871
    Canonical exit: 25 Aug 2026 (T+90)
  • ●
    Executives
    Executives(filed)
    0DART
  • ▲
    상무이사Executives(filed)
    €156kest.0DART
    6,000 sharesShareKRXDART:20260119000026
    Canonical exit: 19 Apr 2026 (T+90)
  • ▲
    COOExecutives(filed)
    €521kest.0DART
    20,000 sharesShareKRXDART:20260119000024
    Canonical exit: 19 Apr 2026 (T+90)
  • ▼
    상무이사Executives(filed)
    €519kest.0DART
    18,000 sharesShareKRXDART:20251219000034
  • ▼
    Related company / holdingExecutives
    €1.4Mest.0DART
    110,286 sharesKRXDART:20250206000625
  • ▲
    이사Executives(filed)
    €268kest.0DART
    30,000 sharesShareKRXDART:20241210000121
    Canonical exit: 10 Mar 2025 (T+90)
  • ▲
    이사Executives(filed)
    €1.3Mest.0DART
    145,720 sharesShareKRXDART:20241210000072
    Canonical exit: 10 Mar 2025 (T+90)
  • ▲
    이사Executives(filed)
    €536kest.0DART
    60,000 sharesShareKRXDART:20241210000116
    Canonical exit: 10 Mar 2025 (T+90)
  • ▲
    이사Executives(filed)
    €116kest.0DART
    13,000 sharesShareKRXDART:20241210000113
    Canonical exit: 10 Mar 2025 (T+90)
  • ▲
    대표이사Executives(filed)
    €8.7Mest.0DART
    1,000,000 sharesShareKRXDART:20241113000604
    Canonical exit: 11 Feb 2025 (T+90)
  • ▲
    Related company / holdingExecutives
    €10.2Mest.0DART
    1,167,388 sharesKRXDART:20241113000461
    Canonical exit: 11 Feb 2025 (T+90)
  • ●
    -Executives
    0DART
    ShareKRXDART:20241113000696
  • ▲
    대표이사Executives(filed)
    €20.1Mest.0DART
    2,300,000 sharesShareKRXDART:20241113000537
    Canonical exit: 11 Feb 2025 (T+90)
  • ▲
    -Executives(filed)
    €14.5Mest.0DART
    1,690,000 sharesShareKRXDART:20241112000450
    Canonical exit: 10 Feb 2025 (T+90)
  • ▲
    Executives
    €14.5Mest.0DART
    1,690,000 sharesKRXDART:20241112000448
    Canonical exit: 5 Feb 2025 (T+90)
  • ▲
    Related company / holdingExecutives
    €7.8Mest.0DART
    1,167,388 sharesKRXDART:20241107000335
    Canonical exit: 5 Feb 2025 (T+90)

18 of 18 declarations

About 토모큐브

토모큐브 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative technologies for medical diagnosis and treatment.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations